Genetic discrimination legislation in Canada: moving from rhetoric to real debate

Nicholls, Stuart G.; Fafard, Patrick

doi:10.1503/cmaj.151170

Cited by 4 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This has been criticized by some scholars for its limited scope, which often allows for discrimination based on medical information concerning familial history of disease (e.g., stroke) or risks that may be largely inherited (e.g., cholesterol level). In the context of insurance, for instance, some scholars object to the idea that differential treatment based on genetic test results should be prohibited, while the use of familial history of disease is acceptable to them (26,54,63,66). They assert that genetic and familial influences both are beyond individual control and can be predictive of individuals' future health.…”

Section: Emerging Issuesmentioning

confidence: 99%

Looking Beyond GINA: Policy Approaches to Address Genetic Discrimination

Joly

Dupras

Pinkesz

et al. 2020

Annu. Rev. Genom. Hum. Genet.

View full text Add to dashboard Cite

Genetic discrimination (GD) is consistently associated with research and innovation in genetics. Over recent decades, countries around the world have attempted to address GD using various policy measures. In this article, we survey these approaches and provide a critical commentary on their advantages and disadvantages. Our examination begins with regions featuring extensive policy-making activities (North America and Europe), followed by regions with moderate policy-making activities (Australia, Asia, and South America) and regions with minimal policy-making activities (the Middle East and Africa). Our analysis then turns to emerging issues regarding genetic testing and GD, including the expansion of multiomics sciences and direct-to-consumer genetic tests outside the health context. We additionally survey the shortcomings of current normative approaches addressing GD. Finally, we conclude by highlighting the evolving nature of GD and the need for more innovative policy-making in this area. Expected final online publication date for the Annual Review of Genomics and Human Genetics, Volume 21 is August 31, 2020. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

show abstract

Section: Emerging Issuesmentioning

confidence: 99%